Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ARENA PHARMACEUTICALS INC | Financial_Report.xls |
| EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - ARENA PHARMACEUTICALS INC | d268596dex211.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ARENA PHARMACEUTICALS INC | d268596dex311.htm |
| EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ARENA PHARMACEUTICALS INC | d268596dex232.htm |
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - ARENA PHARMACEUTICALS INC | d268596dex321.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ARENA PHARMACEUTICALS INC | d268596dex312.htm |
| EX-3.8 - CERTIFICATE OF DESIGNATIONS - ARENA PHARMACEUTICALS INC | d268596dex38.htm |
| 10-K - FORM 10-K - ARENA PHARMACEUTICALS INC | d268596d10k.htm |
| EX-10.36 - AMENDMENT NO.5 TO THE TOLL MANUFACTURING AGREEMENT - ARENA PHARMACEUTICALS INC | d268596dex1036.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Arena Pharmaceuticals, Inc.:
We consent to the incorporation by reference in the registration statements on Form S-8 (Nos. 333-45330, 333-45332, 333-62894, 333-86350, 333-135398, and 333-160329) and on Form S-3 (Nos. 333-112542, 333-136023, 333-160983, 333-166481, 333-167498, and 333-177826) of Arena Pharmaceuticals, Inc. of our reports dated March 15, 2012, with respect to the consolidated balance sheets of Arena Pharmaceuticals, Inc. and subsidiaries (the Company) as of December 31, 2011 and 2010, and the related consolidated statements of operations, stockholders’ equity and comprehensive loss, and cash flows for the years then ended, and the effectiveness of internal control over financial reporting as of December 31, 2011, which reports appear in the December 31, 2011 annual report on Form 10-K of Arena Pharmaceuticals, Inc.
/s/ KPMG LLP
San Diego, California
March 15, 2012